A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial.
about
A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A potentially neuroprotective ...... pective phase II GINECO trial.
@en
A potentially neuroprotective ...... pective phase II GINECO trial.
@nl
type
label
A potentially neuroprotective ...... pective phase II GINECO trial.
@en
A potentially neuroprotective ...... pective phase II GINECO trial.
@nl
prefLabel
A potentially neuroprotective ...... pective phase II GINECO trial.
@en
A potentially neuroprotective ...... pective phase II GINECO trial.
@nl
P2093
P2860
P921
P1476
A potentially neuroprotective ...... spective phase II GINECO trial
@en
P2093
Béatrice Weber
Dominique Spaeth
Eric Pujade-Lauraine
GINECO group, France
Gabriel Yazbek
Isabelle Ray-Coquard
Jérôme Alexandre
Jérôme Dauba
Jérôme Meunier
Laure Copel
P2860
P2888
P304
P356
10.1007/S00520-013-1748-0
P577
2013-02-19T00:00:00Z